LIFECORE BIOMEDICAL, INC. Goodwill, Impaired, Accumulated Impairment Loss
LIFECORE BIOMEDICAL, INC. (LFCR) had Goodwill, Impaired, Accumulated Impairment Loss of $0 as of 2025-12-31, per its 10-KT filed 2026-03-16.
Financial Statements › Notes
us-gaap:GoodwillImpairedAccumulatedImpairmentLoss · last filed 2026-03-16
- 2025-12-31: Goodwill, Impaired, Accumulated Impairment Loss $0.00.
- 2024-11-30: Goodwill, Impaired, Accumulated Impairment Loss $0.00.
- 2018-05-27: Goodwill, Impaired, Accumulated Impairment Loss $38.80M.
- 2017-05-28: Goodwill, Impaired, Accumulated Impairment Loss $38.80M.
| Period end | Goodwill, Impaired, Accumulated Impairment Loss |
|---|---|
| 2025-12-31 | $0.00 10-KT · filed 2026-03-16 |
| 2024-11-30 | $0.00 10-K · filed 2025-08-07 |
| 2018-05-27 | $38.80M 10-K · filed 2018-08-09 |
| 2017-05-28 | $38.80M 10-K/A · filed 2018-03-15 |
| 2016-05-29 | $38.80M 10-K/A · filed 2018-03-15 |
| 2015-05-31 | $4.80M 10-K · filed 2016-08-01 |
| 2014-05-25 | $4.80M 10-K · filed 2015-07-31 |
| 2013-05-26 | $4.80M 10-K · filed 2014-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |